BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6600184)

  • 1. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
    Shackelford DA; Strominger JL
    J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Separation of three class II antigens from a homozygous human B cell line.
    Shackelford DA; Lampson LA; Strominger JL
    J Immunol; 1983 Jan; 130(1):289-96. PubMed ID: 6600185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
    Machamer CE; Cresswell P
    J Immunol; 1982 Dec; 129(6):2564-9. PubMed ID: 6982931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HLA-DR antigens: cellular expression and molecular structure].
    Charron DJ
    Ann Immunol (Paris); 1982; 133D(2):155-69. PubMed ID: 6187269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant chain influences post-translational processing of HLA-DR molecules.
    Schaiff WT; Hruska KA; Bono C; Shuman S; Schwartz BD
    J Immunol; 1991 Jul; 147(2):603-8. PubMed ID: 2071896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure, biosynthesis, and polymorphism of chicken MHC class II (B-L) antigens and associated molecules.
    Guillemot F; Turmel P; Charron D; Le Douarin N; Auffray C
    J Immunol; 1986 Aug; 137(4):1251-7. PubMed ID: 2942601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine Ia-associated invariant chain's processing to complex oligosaccharide forms and its dissociation from the I-Ak complex.
    Holt GD; Swiedler SJ; Freed JH; Hart GW
    J Immunol; 1985 Jul; 135(1):399-407. PubMed ID: 3873494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.
    Lublin DM; Krsek-Staples J; Pangburn MK; Atkinson JP
    J Immunol; 1986 Sep; 137(5):1629-35. PubMed ID: 2427577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.
    Shackelford DA; Lampson LA; Strominger JL
    J Immunol; 1981 Oct; 127(4):1403-10. PubMed ID: 6944380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monensin prevents terminal glycosylation of the N- and O-linked oligosaccharides of the HLA-DR-associated invariant chain and inhibits its dissociation from the alpha-beta chain complex.
    Machamer CE; Cresswell P
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1287-91. PubMed ID: 6608726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthesis and cell surface localization of nonglycosylated human histocompatibility antigens.
    Ploegh HL; Orr HT; Stominger JL
    J Immunol; 1981 Jan; 126(1):270-5. PubMed ID: 7005335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen.
    Shackelford DA; Mann DL; van Rood JJ; Ferrara GB; Strominger JL
    Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4566-70. PubMed ID: 6974868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.
    Lisowska-Grospierre B; Charron DJ; de Préval C; Durandy A; Griscelli C; Mach B
    J Clin Invest; 1985 Jul; 76(1):381-5. PubMed ID: 3860509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of HLA-DR antigen glycosylation by serial lectin affinity chromatography.
    Neel D; Giner M; Merlu B; Turmel P; Goussault Y; Charron DJ
    Mol Immunol; 1985 Sep; 22(9):1053-9. PubMed ID: 3865052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allele and locus-specific differences in cell surface expression and the association of HLA class I heavy chain with beta 2-microglobulin: differential effects of inhibition of glycosylation on class I subunit association.
    Neefjes JJ; Ploegh HL
    Eur J Immunol; 1988 May; 18(5):801-10. PubMed ID: 2967765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosynthesis pathway of gp90MEL-14, the mouse lymph node-specific homing receptor.
    van de Rijn M; Weissman IL; Siegelman M
    J Immunol; 1990 Sep; 145(5):1477-82. PubMed ID: 2166761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis and processing of class II histocompatibility antigens.
    Cresswell P; Blum JS; Kelner DN; Marks MS
    Crit Rev Immunol; 1987; 7(1):31-53. PubMed ID: 3545672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary structure of human class II histocompatibility antigens (HLA-D). I. Isolation, purification and characterization of the HLA-D alpha/beta chain complex from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2, 2;DR2,2;MT1,1;DC1,1;MB1,1].
    Thinnes FP; Egert G; Götz H; Pauly E; Altevogt P; Kölbel S; Wernet P; Kratzin H; Yang C; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1277-89. PubMed ID: 6334638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides.
    Hawkins LK; Wold WS
    Virology; 1995 Jul; 210(2):335-44. PubMed ID: 7618271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.